Acetaminophen; Ibuprofen Sodium Patent Expiration
Acetaminophen; Ibuprofen Sodium is Used for managing moderate to severe pain in adults with the assistance of opioid analgesics. It was first introduced by Hikma Pharmaceuticals Usa Inc
Acetaminophen; Ibuprofen Sodium Patents
Given below is the list of patents protecting Acetaminophen; Ibuprofen Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Combogesic Iv | US11213498 | Aqueous formulation comprising paracetamol and ibuprofen | Jan 14, 2036 | Hikma |
| Combogesic Iv | US11389416 | Aqueous formulation comprising paracetamol and ibuprofen | Jul 17, 2035 | Hikma |
| Combogesic Iv | US12083087 | Aqueous formulation comprising paracetamol and ibuprofen | Jul 17, 2035 | Hikma |
| Combogesic Iv | US11446266 | Combination composition | Oct 26, 2031 | Hikma |
| Combogesic Iv | US11896567 | Combination composition | Oct 26, 2031 | Hikma |
Acetaminophen; Ibuprofen Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List